国药股份

- 600511

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
国药股份(600511) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入3,802,853.972,475,650.301,212,214.264,969,604.553,652,966.68
营业收入3,802,853.972,475,650.301,212,214.264,969,604.553,652,966.68
二、营业总成本3,631,106.902,362,600.271,158,400.504,719,408.893,480,263.46
营业成本3,535,975.732,300,339.891,127,005.584,570,477.613,370,207.69
营业税金及附加8,894.145,734.882,682.2011,473.608,101.19
销售费用58,215.1438,869.2120,145.4596,237.8368,154.87
管理费用30,974.4720,045.3810,053.4046,712.7930,798.30
财务费用-7,366.71-5,268.68-2,880.28-12,612.67-2,315.64
研发费用4,414.122,879.591,394.167,119.745,317.06
资产减值损失----------
公允价值变动收益------1,081.753,472.51
投资收益31,641.3624,032.8410,497.8735,895.1828,697.68
其中:对联营企业和合营企业的投资收益32,021.2624,324.8810,218.6145,653.8732,918.94
汇兑收益----------
三、营业利润198,926.15132,960.8761,379.88294,435.78199,380.07
加:营业外收入134.0099.0562.99300.55292.71
减:营业外支出2,476.771,276.5189.231,647.311,067.39
其中:非流动资产处置损失----------
四、利润总额196,583.39131,783.4161,353.65293,089.02198,605.39
减:所得税费用39,090.6725,416.1111,841.8059,641.9540,414.31
五、净利润157,492.72106,367.3049,511.85233,447.07158,191.09
归属于母公司所有者的净利润148,127.18100,051.0745,945.45214,599.87146,229.59
少数股东损益9,365.536,316.233,566.3918,847.2011,961.50
六、每股收益
基本每股收益(元/股)1.96321.32610.60892.84431.9381
稀释每股收益(元/股)1.96321.32610.60892.84431.9381
七、其他综合收益-444.62-852.66-585.32510.26101.31
八、综合收益总额157,048.10105,514.6448,926.52233,957.34158,292.39
归属于母公司所有者的综合收益总额147,682.5699,198.4145,360.13215,110.14146,330.89
归属于少数股东的综合收益总额9,365.536,316.233,566.3918,847.2011,961.50
下载全部历史数据到excel中 返回页顶